NXTC

NextCure, Inc. (NXTC) SWOT Analysis Analysis (2026)

Invetso Score: 3.9/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.2 (Moderate)

Negative TTM ROIC indicates weaker capital efficiency than profitable peers, but the company still appears to preserve liquidity better than more levered competitors.

A very large negative cash conversion cycle suggests customers fund working capital, which can support cash generation relative to peers with longer cash gaps.

Current and quick ratios of 3.47 imply ample short-term liquidity, positioning NXTC more conservatively than peers with tighter balance sheets.

Weaknesses

Score:

TTM ROIC of -2.6% shows capital is not earning its cost, leaving NXTC structurally behind peers that compound value through positive returns.

Debt-to-equity of 0.35 and net debt-to-EBITDA of 0.26 are manageable, but they do not offset the absence of demonstrated operating profitability versus peers.

Missing margin data limits precision, yet the available return profile still signals weaker economic quality than peer companies with durable earnings power.

Opportunities

Score:

If NXTC converts its strong liquidity into higher-return deployment, it could narrow the gap with peers that already monetize balance-sheet flexibility more effectively.

The negative cash conversion cycle provides working-capital optionality, which can support faster reinvestment than peers that must fund growth externally.

Low leverage leaves room to absorb operational improvement, giving NXTC more financial flexibility than highly indebted peers if demand conditions improve.

Threats

Score:

Peers with positive ROIC can compound capital faster, making NXTC vulnerable to persistent share and valuation underperformance if returns stay negative.

If working-capital dynamics normalize, the current cash advantage could shrink, exposing NXTC to peers with stronger recurring earnings quality.

Limited evidence of margin strength increases the risk that NXTC remains structurally behind peers in pricing power and operating leverage.

Overall Score

Score:

NXTC’s peer positioning is weakened by negative capital returns and limited evidence of durable operating profitability, despite solid liquidity and modest leverage.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on NextCure, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →